Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeSeelos Therapeutics

      Seelos Therapeutics

      Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference
      Other

      Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

      September 9, 2022
      Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson’s Research for SLS-004
      Other

      Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson’s Research for SLS-004

      August 24, 2022

       

      LATEST NEWS

      • Investing News Nike Faces Earnings Dilemma
      • Investing News Nike’s Q4 2026 Earnings Review
      • Investing News AeroVironment’s Robust Earnings Boost
      • Investing News AeroVironment Stock Soars on Earnings
      • Investing News European Earnings: Second Quarter Insights

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026